Tenax Therapeutics(TENX) - 2019 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C., 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Commission File No. 001-34600 TENAX THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of Incorporation or organization) (I.R.S. Employer Identification No.) Delaware 26-2593535 | Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Wh ...